** Cancer therapy maker Legend Biotech's LEGN.O shares rise 5.6% to $35.96

** Co posts Q4 adj. net loss of 16 cents per share, compared to a loss of 24 cents per share a year earlier

** Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which co believes will provide financial runway into Q2 2026

** LEGN has fallen 46.1% in the past 12 months

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))